The FDA clearance of glucose represents one of many milestones to come for Epocal and for healthcare as we continue to expand the test menu of the first wireless and cost effective point of care testing system. said Imants Lauks, Epocal President and Founder. We are very excited to offer an award winning technology that enables hospitals worldwide to improve the delivery of patient care, reduce their operating expenses and operate more efficiently.
